🧬 biology

Disease Associated Loss of an MHC Locus in the Tasmanian Devil: Evolutionary Consequences for Devil Facial Tumour Disease Resistance

This study provides the first empirical evidence that the emergence of devil facial tumour disease has driven the adaptive loss of a specific MHC-I locus and a reduction in MHC diversity in Tasmanian devils, reshaping their immune gene architecture to enhance tumour resistance while potentially compromising future resilience to other pathogens.

Original authors: Carolyn Hogg, Kimberley Batley, Ruth Pye, Luke Silver, Katherine Farquharson, Yuanyuan Cheng, Andy Flies, Katherine Belov

Published 2026-07-08

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Carolyn Hogg, Kimberley Batley, Ruth Pye, Luke Silver, Katherine Farquharson, Yuanyuan Cheng, Andy Flies, Katherine Belov

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: A Genetic Game of "Spot the Difference"

Imagine the Tasmanian devil's immune system as a security team, and the MHC-I genes as their ID badges. These badges tell the security team, "This cell belongs here; it's one of us."

Usually, having a huge variety of these ID badges is a good thing. It helps the security team recognize a wide range of intruders (like viruses or bacteria). However, the Tasmanian devil is facing a very strange enemy: Devil Facial Tumour Disease (DFTD). This isn't a virus; it's a cancer that spreads from one devil to another like a contagious infection.

The cancer cells are essentially "hijackers." They have stolen the original ID badges from the first devil they infected. Because all the devils in the population are genetically very similar, the cancer's ID badges often look exactly like the badges of the new host. The security team sees the cancer, thinks, "Oh, that's one of us," and lets it walk right in.

The Discovery: Losing a Badge to Win the Fight

This paper reports a surprising discovery: To survive this cancer, the devils are losing one of their ID badges entirely.

The Analogy:
Imagine a security checkpoint where the intruders (the cancer) are wearing a specific uniform (a specific ID badge).

The Old Strategy: The security team tries to wear more different uniforms to confuse the intruders.
The New Strategy (What the paper found): The security team realizes that if they stop wearing the exact same uniform as the intruder, the intruder becomes obvious. So, they start throwing away that specific uniform.

In scientific terms, the paper found that devils who have a deletion (a missing piece) of a specific gene called Saha-UA are much better at fighting the cancer.

The cancer cells have the Saha-UA gene.
The devils that lack the Saha-UA gene look different from the cancer.
Because they look different, the devil's immune system recognizes the cancer as an invader and attacks it, producing antibodies (weapons) to fight it.

The Evidence: Nature's "Survival of the Fittest" in Real-Time

The researchers didn't just guess this; they watched it happen over time.

The "Who Survived" Test: They looked at devils that had survived the disease longer than usual (some lived to be 6 or 7 years old, while most die by age 3). Almost all of these long-lived survivors were missing the Saha-UA gene.
The "Time Travel" Test: They compared devil populations from 10 years ago to today. In areas where the cancer has been around for a long time, the number of devils missing the Saha-UA gene has gone up significantly. In areas where the cancer hasn't arrived yet, the number of devils with the gene stayed the same.
The "Match" Score: They created a "transplant score" (like in human organ donation). If a devil's ID badges matched the cancer's, the score was low (bad). If they didn't match, the score was high (good). Devils with high mismatch scores were the ones making antibodies and surviving.

The Twist: "Death" Can Be a Good Thing

In biology, there is a theory called the "Birth-and-Death" model. Usually, when we talk about a gene "dying" (being lost or deleted), we think of it as a mistake or a passive event where a gene just stops working because it's no longer needed.

This paper flips that idea on its head. It shows that gene death can be an active, smart strategy. The cancer pressure is so strong that it is forcing the devils to lose a functional gene to survive. It's like a house fire forcing you to throw away a valuable painting to save your life. The loss of the gene is actually the key to survival.

The Catch: A Double-Edged Sword

The paper ends with a cautionary note. While losing this gene helps the devils fight this specific cancer, it might make them weaker against other threats.

The Analogy:
Imagine the devils threw away their "Fire Extinguisher" badge because it looked too much like the arsonist's badge. Now they can spot the arsonist easily. But, if a real fire starts (like a new virus or flu), they might not have the right tool to put it out because they threw away that specific badge.

The researchers warn that while this evolutionary change is saving them from the cancer right now, it reduces their overall genetic diversity. This could make them more vulnerable to new diseases in the future.

Summary

The Problem: A contagious cancer is killing Tasmanian devils because the cancer looks too much like the devils themselves.
The Solution: The devils are evolving to lose a specific gene (Saha-UA) so they look different from the cancer.
The Result: Devils without this gene can spot the cancer, fight it, and live longer. This "gene death" is happening rapidly in the wild.
The Risk: While this helps against the cancer, having fewer types of immune genes might make the species less ready for other future diseases.

Technical Summary: Disease-Associated Loss of an MHC Locus in the Tasmanian Devil

Problem Statement
The emergence of Devil Facial Tumour Disease (DFTD), a clonal transmissible cancer, has imposed severe selective pressure on Tasmanian devil (Sarcophilus harrisii) populations. While the "birth-and-death" model of Major Histocompatibility Complex (MHC) evolution posits that gene loss is typically a passive outcome of duplication, redundancy, and relaxed selection over macroevolutionary timescales, it remains unresolved whether contemporary disease pressure can actively drive the loss of a functional MHC locus. Specifically, it is unknown if the specific immune evasion strategies of DFT1 (downregulation of MHC-I) have selected for host genotypes that reduce MHC-I similarity to the tumour, potentially leading to the adaptive "death" of a functional MHC-I gene within a wild population.

Methodology
The study employed a multi-faceted approach combining long-read MHC genotyping, temporal population sampling, and functional immune phenotyping:

Sample Collection: Serum and ear biopsy samples were collected from 592 wild Tasmanian devils across nine field sites in Tasmania. Samples included individuals from sites with varying durations of DFT1 exposure (ranging from 9 to 28 years) and one long-term disease-free site (Woolnorth).
Immune Phenotyping: Serum samples from 116 devils were analyzed via flow cytometry to detect anti-MHC-I antibodies. Cells were tested against DFT1 cell lines with and without interferon-gamma (IFN-γ) treatment to induce MHC-I surface expression. Antibody responses were quantified using the Median Fluorescence Intensity Ratio (MFIR).
Genotyping: Long-read amplicon sequencing (PacBio Sequel II) was used to genotype the three classical MHC-I loci (Saha-UA, Saha-UB, Saha-UC) in 61 devils with known antibody/DFT1 status and two DFT1 cell lines. Alleles were grouped into supertypes based on peptide-binding residue properties.
Statistical Analysis: Generalized Linear Models (GLMs) were used to correlate MHC-I genotypes (alleles, supertypes, and deletion status) with antibody responses. Temporal trends in allele frequencies were analyzed using logistic regression against the years since DFTD introduction, controlling for site-specific effects and neutral genetic drift.
Evolutionary Analysis: Segmental duplication analysis (using biser) and synonymous substitution rate calculations ($dS$) were performed to estimate the divergence times of the Saha-UA, UB, and UC genes from a putative ancestral gene (Saha-UD).

Key Results

Association Between MHC Mismatch and Immune Response: Devils with MHC-I genotypes that differed from the DFT1 tumour were significantly more likely to mount anti-MHC-I antibody responses. Specifically, a non-functional deletion of the Saha-UA gene (resulting in a pseudogene) was strongly associated with antibody production ( $p < 0.01$ ). Conversely, the presence of the Saha-UC allele shared with DFT1 and the "supertype 2" (shared with DFT1) had strong negative effects on antibody responses.
Directional Selection and Gene Loss: In populations affected by DFT1, the frequency of the non-functional Saha-UA deletion increased significantly over time, particularly in sites where the disease has been present for ~15 years. This trend was absent in the disease-free Woolnorth population, confirming the shift is disease-driven rather than neutral drift.
Survival Advantage: Devils carrying the Saha-UA deletion and lacking tumour-matching supertypes were more likely to survive to older ages (≥4 years), a rare outcome in diseased populations where most individuals die before age 3.
MHC Architecture Remodeling: The study observed a directional decline in MHC-I supertypes shared with DFT1 (notably supertype 2) and a concurrent rise in the Saha-UA deletion. This indicates a reshaping of the MHC-I gene architecture at the population level.
Evolutionary Context: Phylogenetic analysis suggests the three classical MHC-I genes (UA, UB, UC) arose from a recent duplication event (0.66–2.01 MYA) from an ancestral gene (UD), indicating the repertoire is evolutionarily dynamic.

Significance and Claims
The paper claims to provide the first empirical evidence of a naturally occurring disease driving the adaptive loss ("death") of a functional MHC-I locus in a wild vertebrate.

Refinement of Evolutionary Models: The findings extend the classical birth-and-death model by demonstrating that gene "death" can be a direct, positive selection outcome driven by contemporary disease pressure, rather than solely a passive consequence of relaxed constraint.
Host-Tumour Coevolution: The study establishes a direct link between host genotype and a functional immune phenotype (antibody production), providing robust genetic evidence that Tasmanian devils are actively co-evolving with a transmissible cancer.
Context-Dependent Immunity: The results challenge the assumption that greater MHC diversity is always advantageous. In the specific context of DFT1, the loss of a locus (Saha-UA) that reduces host-tumour similarity is adaptive, enhancing allorecognition.
Conservation Implications: While this evolutionary response enhances resistance to DFT1, the authors caution that the contraction of MHC-I diversity may reduce resilience to future emerging pathogens (e.g., avian influenza). Consequently, conservation strategies must balance the selection for DFT1-resistant genotypes with the maintenance of broader immunogenetic variation.